Advertisement

Topics

Auven Therapeutics Company Profile

06:27 EST 20th February 2017 | BioPortfolio

Auven Therapeutics is a private equity company focused on the healthcare industry.

The Company’s strategy is to acquire controlling ownership in promising therapeutic products or platforms. The value of these therapeutic assets is then significantly enhanced by global development programs prior to selling them as clinically and commercially validated products to established pharmaceutical companies.

Auven Therapeutics has built a diversified portfolio of biologic and small molecule therapeutic candidates for a wide range of therapeutic indications. The Company’s existing pipeline addresses critical unmet medical needs in cancer, ophthalmic conditions, women’s health and orphan diseases.

It has ownership of or a controlling interest in the therapeutic assets of ADC Therapeutics, Spirogen, Resolvyx and Kiacta, and a minority investment in Kolltan and Sprout Pharmaceuticals.

Founded in 2007 by industry veterans Stephen Evans-Freke and Dr. Peter B. Corr, Auven Therapeutics Management L.L.L.P. is an investment advisor with its principal place of business in the US Virgin Islands. It manages Auven Therapeutics Holdings L.P., a private equity fund, which has its registered office and principal place of business in the British Virgin Islands. Auven Therapeutics Development, the operating company of Auven Therapeutics Holdings L.P. manages drug development from its bases in Lausanne, Switzerland, New York, USA and Hamilton, Bermuda.

Location

6501 Redhook Plaza, Suite 201
St. Thomas
USVI
00802
USVI

Contact

Phone: +1-340-779-6908 (phone)
Fax: +1-340-714-5192 (fax)
Email: info@auventx.com


News Articles [1819 Associated News Articles listed on BioPortfolio]

Auven to Sell Subsidiary, Dry Eye Disease Candidate to Sun Pharma

Auven Therapeutics said today it will sell its Ocular Technologies subsidiary—whose key asset is the Phase III dry eye disease treatment candidate Seciera TM (OTX-101)—to Sun Pharma for $40 millio...

After Failed Phase III, Auven Therapeutics (previously known as Celtic Therapeutics Management L.L.L.P.) to Terminate the KIACTA Program

  Life Sciences Jobs   ...

BRIEF-Auven Therapeutics announces sale of Ocular Technologies to Sun Pharma

* Auven Therapeutics announces sale of Ocular Technologies to Sun Pharma

ADC Therapeutics closes $105mm third round

ADC Therapeutics SARL raised $105mm through its third funding round from new and returning investors including Auven Therapeutics and AstraZeneca. The company, which is developing antibody-drug conjug...

BRIEF-Bellus Health provides update on pipeline

* Auven Therapeutics has decided to terminate Kiacta program for treatment of AA Amyloidosis

Ep. 34: Versant closes oversubscribed sixth healthcare-focused fund

Versant Ventures closes its newest fund, a new stem cell company is born in the MaRs Discovery District and Auven Therapeutics official pulls the plug on the KIACTA™ AA amyloidosis program. We have ...

ADC Therapeutics raises $105M

Oncology company ADC Therapeutics S.a.r.l. (Lausanne, Switzerland) raised $105 million in an oversubscribed round from existing investors Auven Therapeutics Management LLLP (St. Thomas, Virgin Islands...

After Failed Phase III, Auven to Terminate the KIACTA Program

  Life Sciences Jobs   ...

Drugs and Medications [0 Results]

None

Clinical Trials [22 Associated Clinical Trials listed on BioPortfolio]

A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...

Beat AML Core Study

In this study, DNA sequencing, computational biology modeling, and ex vivo drug sensitivity assays will be utilized to define clinically relevant gene mutations and identify potential ther...

Localized Therapeutics for the Treatment of Gastrointestinal Disorders II

The purpose of this study is to investigate a novel thermosensitive topical gel formulation for the treatment of inflammatory bowel disease (IBD), specifically ulcerative colitis.

Amnis Therapeutics Thrombectomy Device-First in Man (FIM) Safety and Performance Study

Prospective, single-arm, open label, Safety and Performance clinical investigation.

A Gene Transfer Study for Hemophilia A

This clinical research study is being conducted by Spark Therapeutics, Inc. to determine the safety and efficacy of the factor VIII gene transfer treatment with SPK-8011 in individuals wit...

Companies [1086 Associated Companies listed on BioPortfolio]

Auven Therapeutics

Auven Therapeutics is a private equity company focused on the healthcare industry. The Company’s strategy is to acquire controlling ownership in promising therapeutic products or platforms. ...

Auven Therapeutics

Auven Therapeutics is a private equity company focused on the healthcare industry. The Company’s strategy is to acquire controlling ownership in promising therapeutic products or platforms. ...

ADC Therapeutics Sarl

ADC Therapeutics (ADCT) is a Swiss-based oncology drug development company that specializes in the development of proprietary Antibody Drug Conjugates (ADCs) targeting major cance...

ADC Therapeutics

ADC Therapeutics sarl (ADCT) is a Swiss-based oncology drug development company that specializes in the development of proprietary Antibody Drug Conjugates (ADCs) targeting major ...

Aeris Therapeutics

Aeris Therapeutics is an emerging medical therapeutics company specializing in the development and commercialization of novel treatments for patients with emphysema and other adva...

More Information about "Auven Therapeutics" on BioPortfolio

We have published hundreds of Auven Therapeutics news stories on BioPortfolio along with dozens of Auven Therapeutics Clinical Trials and PubMed Articles about Auven Therapeutics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Auven Therapeutics Companies in our database. You can also find out about relevant Auven Therapeutics Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...


Corporate Database Quicklinks



Searches Linking to this Company Record